TABLE II.
Primary and Secondary Outcomes
| Allograft | Bioactive Glass | P Value | |
|---|---|---|---|
| Recurrence of the lesion (no. [%]) | 12 (46%) | 10 (40%) | 0.66 |
| Size of recurrence at 2-yr follow-up* (mL) | 3.3 (0-13.2) | 2.2 (0-16.6) | 0.43 |
| Reoperation (no. [%]) | 4 (15%) | 6 (24%) | 0.50 |
| Hospital stay* (days) | 2.4 (1-5) | 2.9 (1-10) | 0.66 |
| MSTS score* | |||
| Preoperative | 23.4 (3-30) | 22.4 (0-30) | 0.91 |
| 6 weeks | 23.3 (6-30) | 22.7 (8-30) | 0.67 |
| 3 months | 27.0 (13-30) | 27.4 (22-30) | 0.41 |
| 6 months | 28.5 (23-30) | 29.0 (24-30) | 0.20 |
| 12 months | 28.7 (25-30) | 27.9 (21-30) | 0.50 |
| 24 months | 29.1 (25-30) | 28.7 (25-30) | 0.51 |
The values are given as the mean, with the range in parentheses.